Survival in stage IV ovarian cancer with increased use of debulking surgery and bevacizumab | International Journal of Gynecologic Cancer

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About

YouTube

Podcasts

Zoom Journal Club
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

Original research

Survival in stage IV ovarian cancer with increased use of debulking surgery and bevacizumab

Online download statistics by month:

Online download statistics by month: January 2023 to September 2024

	Abstract	Full	Pdf
Jan 2023	675	33	24
Feb 2023	324	12	9
Mar 2023	157	9	6
Apr 2023	512	34	24
May 2023	229	15	15
Jun 2023	152	1	3
Jul 2023	112	4	9
Aug 2023	179	1	3
Sep 2023	92	2	3
Oct 2023	86	1	4
Nov 2023	92	5	6
Dec 2023	119	5	1
Jan 2024	111	5	2
Feb 2024	94	9	6
Mar 2024	145	3	2
Apr 2024	92	4	3
May 2024	111	2	2
Jun 2024	100	9	9
Jul 2024	112	3	2
Aug 2024	48	2	3
Sep 2024	28	0	0
Total	3570	159	136